Product image of Metfogamma (Metformin Hydrochloride) supplied by GNH India

Metfogamma

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metfogamma (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metfogamma, is a Biguanide presented as an oral tablet for oral use. It reduces hepatic glucose production and improves insulin sensitivity, thereby treating type 2 diabetes mellitus in adults. It is indicated for adult patients with inadequate glycemic control when diet and exercise alone are insufficient.

GNH India supplies Metfogamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance, batch‑to‑batch consistency, and reliable logistics for global distribution and patient access.

Manufacturer / TM Owner

Wörwag Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metfogamma, containing metformin hydrochloride, is used in the management of disorders related to glucose metabolism.

  • Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.
  • Prediabetes (impaired glucose tolerance): delays progression to type 2 diabetes when combined with lifestyle modifications.
  • Polycystic ovary syndrome (PCOS): reduces insulin resistance and may help restore regular menstrual cycles.

How It Works

  • Metformin hydrochloride acts primarily by inhibiting hepatic gluconeogenesis, thereby decreasing hepatic glucose output. It also enhances peripheral glucose uptake by increasing insulin‑mediated activation of AMP‑activated protein kinase (AMPK) in muscle and adipose tissue, which improves insulin sensitivity and reduces intestinal glucose absorption.

Side Effects

Metfogamma may cause a range of adverse reactions, from mild gastrointestinal discomfort to rare but serious metabolic disturbances.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: frequent loose stools, especially during treatment initiation.
  • Abdominal discomfort: cramping or bloating.
  • Metallic taste: transient alteration in taste perception.
  • Loss of appetite: reduced desire to eat.
  • Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: life‑threatening accumulation of lactate, especially in renal impairment.
  • Severe hypoglycemia: when combined with other antidiabetic agents.
  • Hepatic failure: rare liver dysfunction.
  • Allergic reactions: rash, pruritus, or angioedema.
  • Pancreatitis: inflammation of the pancreas.
  • Skin reactions: severe cutaneous adverse reactions such as Stevens‑Johnson syndrome.

Precautions & Warnings

Before initiating Metfogamma, clinicians should evaluate patient‑specific risk factors and monitor relevant clinical parameters.

  • Renal function: assess creatinine clearance and adjust dose in renal impairment.
  • Hepatic function: evaluate liver enzymes to reduce risk of lactic acidosis.
  • Cardiovascular status: monitor for heart failure exacerbation.
  • Concomitant medications: review drugs that may increase risk of hypoglycemia or lactic acidosis.
  • Elderly patients: start with lower doses and titrate slowly.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Metfogamma can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate lactic acidosis; discontinue metformin before imaging.
  • Cimetidine: can increase metformin plasma concentrations.
  • Alcohol: potentiates risk of lactic acidosis.
  • Other antidiabetic agents (e.g., sulfonylureas, insulin): increase hypoglycemia risk.
  • Renally excreted drugs (e.g., digoxin): may require dose adjustment.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask hypoglycemia symptoms.
  • ACE inhibitors/ARBs: monitor renal function and potassium.
  • Statins: watch for rare myopathy when combined.
  • Warfarin: monitor INR as metformin may affect anticoagulation control.
  • Thyroid hormones: assess glycemic control when dosage changes occur.

Frequently Asked Questions

Metfogamma contains metformin hydrochloride, an oral antidiabetic medication indicated for the treatment of type 2 diabetes mellitus in adults. It helps lower elevated blood glucose levels by improving the body’s response to insulin and reducing glucose production in the liver.

Metformin hydrochloride primarily inhibits hepatic gluconeogenesis, which reduces the amount of glucose released by the liver. It also activates AMP‑activated protein kinase (AMPK) in muscle and fat cells, enhancing insulin‑mediated glucose uptake and improving peripheral insulin sensitivity.

The dosage of Metfogamma is individualized by the prescribing clinician based on the patient’s glycemic targets, renal function, and tolerability. The prescriber determines the appropriate starting dose and any subsequent titration schedule.

The safety of metformin during pregnancy or lactation should be evaluated by a healthcare professional. While some guidelines allow its use in certain pregnant patients with gestational diabetes, the decision depends on risk‑benefit assessment and available clinical data.

To order Metfogamma, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metfogamma (metformin) belongs to the biguanide class and is often first‑line therapy for type 2 diabetes because of its efficacy, low risk of hypoglycemia, and favorable impact on weight. Compared with sulfonylureas or insulin, metformin does not cause weight gain and has a well‑established safety profile.

Metfogamma should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, heat, and direct sunlight to maintain product stability throughout its shelf life.

Metfogamma is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets are swallowed whole with a glass of water; they should not be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

The most serious adverse reactions include lactic acidosis, a rare but potentially fatal condition, and severe hypoglycemia when combined with other glucose‑lowering agents. Prompt medical attention is required if patients experience unexplained muscle pain, rapid breathing, or persistent fatigue.

Metfogamma is contraindicated in patients with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and those receiving iodinated contrast studies without appropriate discontinuation of the drug.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT